IL-27: An endogenous constitutive repressor of human monocytes.

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Michael FrangiehElizabeth M Bradshaw

Abstract

Interleukin (IL)-27 is a pleiotropic cytokine that initially was described as being pro-inflammatory and an inducer of T helper (Th)1 cells. In contrast, it has also been described as an anti-inflammatory cytokine in that it suppresses pro-inflammatory Th17 cells and induces anti-inflammatory IL-10 producing T regulatory (Tr)1 cells. While the majority of studies have been focused on the effects of IL-27 on T cells, human antigen-presenting cells express high levels of the IL-27 receptor ex vivo, in addition to being the major producer of IL-27. We report here that human monocytes are repressed by endogenous IL-27, in that the addition of an anti-IL-27 neutralizing antibody increases the production of pro-inflammatory cytokines ex vivo. We observed that neutralizing monocyte-derived IL-27 leads to increased IL-17A production by CD4+ T cells and a down-regulation of the IL-17 modulating ectonucleotidase CD39 on monocytes. The locus that contains the IL27 gene has been linked to susceptibility for type 1 diabetes (T1D). Interestingly, ex vivo monocytes from subjects with T1D produce more IL-27 suggesting this upregulation of IL-27 acts as a negative feedback loop to attempt to counterbalance the pro-inflammatory immune response i...Continue Reading

Citations

Mar 18, 2021·Clinical & Translational Immunology·Marie-Laure ClénetNathalie Arbour

❮ Previous
Next ❯

Related Concepts

Related Feeds

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
George D Kalliolias, Lionel B Ivashkiv
Advances in Experimental Medicine and Biology
Qinghong Wang, Jianguo Liu
© 2022 Meta ULC. All rights reserved